Welcome to our dedicated page for Revvity SEC filings (Ticker: RVTY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Revvity, Inc.'s SEC filings document operating results, governance matters and capital-structure disclosures for a Massachusetts-incorporated life sciences and diagnostics company. Its 8-K reports furnish quarterly and annual financial results, preliminary performance updates, Regulation FD investor presentation materials and other material-event disclosures.
Proxy and annual-meeting filings describe director elections, auditor ratification, advisory executive-compensation votes and shareholder-approved bylaw amendments, including the ability of holders of 25% of the company's stock to call a special meeting. Other current reports identify registered securities, including RVTY common stock and 1.875% notes due 2026 listed on the New York Stock Exchange, as well as officer appointments and related governance changes.
REVVITY, INC. officer Maxwell Krakowiak reported two tax-related stock transactions. On February 17, 2026, he disposed of 1,457 and 902 shares of common stock at $96.03 per share.
According to the footnotes, these shares were surrendered to satisfy tax withholding obligations upon the vesting of restricted stock and restricted stock units originally granted on February 16, 2023, as required under his equity award agreements, rather than being discretionary open-market sales.
REVVITY, INC. officer Joel S. Goldberg reported a disposition of common stock tied to tax withholding. On February 17, 2026, he surrendered 1,733 shares of common stock at $96.03 per share to satisfy withholding taxes upon vesting of restricted stock granted on February 16, 2023, leaving 41,514 shares held directly.
An additional 63,709 shares are held indirectly in the Goldberg Irrevocable 2021 Trust for the sole benefit of his children, for which his spouse serves as trustee. Goldberg disclaims beneficial ownership of these trust-held shares except for any pecuniary interest.
REVVITY, INC. director and officer Prahlad R. Singh reported a tax-related share disposition. On the vesting of restricted stock originally granted on February 16, 2023, he surrendered 6,901 shares of common stock at $96.03 per share to satisfy tax withholding required under his Restricted Stock Agreement. After this transaction, he directly owns 113,312 common shares. An additional 46,583 common shares are held indirectly in an irrevocable trust for the sole benefit of his children, for which his spouse is trustee; he disclaims beneficial ownership of those trust-held securities except for any pecuniary interest.
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G/A reporting a significant passive ownership stake in Revvity Inc. (common stock). The firm reports beneficial ownership of 22,447,103 shares, representing 19.8% of the class, with sole voting and dispositive power over these shares.
The filing notes that clients and funds advised by T. Rowe Price ultimately receive dividends and sale proceeds, and any delegated discretionary authority can be revoked. The T. Rowe Price Capital Appreciation Fund holds 14,366,588 shares, or 12.7% of the class. T. Rowe Price states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control, and expressly denies beneficial ownership beyond its advisory role.
Revvity, Inc. reported equity compensation and tax withholding transactions for senior vice president, global operations, Tajinder S. Vohra. On February 4, 2026, Vohra received 4,448 time-based restricted stock units that vest in three equal annual installments starting on the first anniversary of the grant, bringing his directly owned common stock to 14,531 shares.
On the same date, 359 shares of common stock were surrendered at $101.13 per share to cover tax withholding tied to restricted stock units granted on February 4, 2025. Vohra also received a nonqualified stock option for 12,722 shares at an exercise price of $103.395, vesting in three equal annual installments beginning one year after grant and expiring on February 4, 2033. The filing also corrects an earlier Form 4 by clarifying the three-year vesting schedule for a prior restricted stock unit grant.
Revvity, Inc. insider Prahlad R. Singh, President, Chief Executive Officer and Director, reported multiple equity transactions dated February 4–5, 2026. On February 4, 3,421 shares of common stock were surrendered at $101.13 per share to cover tax withholding on vested restricted stock, and 26,796 time-based restricted stock units were granted, scheduled to vest in three equal annual installments beginning on the first anniversary of grant.
Singh also received a nonqualified stock option for 76,647 shares at an exercise price of $103.395, vesting in three equal annual installments beginning on the first anniversary of grant. On February 5, a previously granted option for 25,525 shares at $92.09 was exercised, and the resulting 25,525 shares of common stock were acquired, followed by market sales totaling 1,307, 12,186, 7,885, 3,079 and 1,068 shares at weighted average prices between $99.02 and $102.52, executed under a Rule 10b5-1 trading plan adopted on February 6, 2025.
After these transactions, Singh reported 120,213 shares of Revvity common stock held directly. An additional 46,583 shares are held indirectly by the Singh Family Trust of 2021 for the sole benefit of his children, with beneficial ownership disclaimed except for any pecuniary interest.
Revvity, Inc. Senior Vice President, Administration, General Counsel and Secretary Joel S. Goldberg reported multiple equity transactions. On February 4, 2026, 869 common shares were withheld at $101.13 to cover taxes on vested restricted stock units, and he received 6,427 time-based restricted stock units plus a nonqualified stock option for 18,383 shares at an exercise price of $103.395, each scheduled to vest in three equal annual installments beginning on the first anniversary of grant.
On February 5, 2026, a previously granted stock option for 12,717 shares was exercised at $92.09 and the same number of common shares was sold in several transactions at weighted average prices between $98.98 and $103.03 under a Rule 10b5-1 trading plan adopted on February 6, 2025. After these transactions, Goldberg directly held 43,247 common shares, and 63,709 additional shares were held indirectly by the Goldberg Irrevocable 2021 Trust for his children, for which he disclaims beneficial ownership except for any pecuniary interest. The filing also corrects a prior Form 4 by clarifying that an earlier restricted stock unit grant vests in three equal annual installments starting one year after grant.
REVVITY, INC. executive Maxwell Krakowiak, Senior Vice President and Chief Financial Officer, reported multiple equity transactions dated February 4, 2026. He surrendered 708 shares of common stock at $101.13 per share to cover tax withholding tied to previously granted restricted stock units.
He also acquired 7,262 time-based restricted stock units at no cost, bringing his directly held common stock to 18,771 shares. In addition, he received a non-qualified stock option for 20,771 shares at an exercise price of $103.395, scheduled to vest in three equal annual installments beginning on the first anniversary of grant. The filing also corrects an earlier vesting schedule disclosure due to an administrative error.
Revvity, Inc. Senior Vice President and Chief Commercial Officer Miriame Victor reported equity compensation activity on February 4, 2026. She received 5,401 time-based restricted stock units at no cost and was granted a nonqualified stock option for 15,449 shares at an exercise price of $103.395 per share.
To cover tax withholding on previously granted restricted stock units that vested the same day, 536 common shares were surrendered at a price of $101.13 per share. After these transactions, she directly holds 19,153 shares of common stock and 15,449 options, all vesting in three equal annual installments beginning on the first anniversary of the grant date.
Revvity, Inc. insider plans to sell common stock under Rule 144. A holder filed to sell 25,525 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $2,557,886.18, when 113,375,621 shares were outstanding. The shares were acquired by exercising a stock option originally granted on 02/05/2019, with the option exercised and paid in cash on 02/05/2026.